Meet our team at booth #74 during the Cell Therapy Manufacturing and Gene Therapy Congress in Amsterdam (The Netherlands), December 3 – 6th, 2019.
Talk by Margherita Neri, Upstream Process Development Manager from Molmed
Critical raw materials in Large scale LV productions for ex vivo gene therapy
Addressing Large-Scale Therapeutic Virus Production Using High Quality Grade PEI-based Transfection Reagents
Our solutions for Cell Manufacturing
in vivo delivery of nucleic acids represents a novel promising approach for some medical applications such as gene and oligonucleotides therapy. Polyplus-transfection® offers a cGMP grade in vivo-jetPEI® which is manufactured in compliance with applicable European Commission (EC) guide to Good Manufacturing Practices (GMP) and FDA requirements for clinical trials phase I to III. This reagent is used worldwide for a growing number of therapies based on nucleic acid delivery.
NEW: in vivo-jetRNA® transfection reagent specifically developed to deliver mRNA in vivo. This reagent can be used to target multiple organs, by using systemic or local injection routes, in various animal models.
FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).
PEIpro® product range for a scalable viral vector production for Gene & Cell therapy.
Meet Jean-Thomas & Perrine to discuss how to improve your transfection experiments. We will be happy to answer all your questions regarding transfection and to present you relevant products adapted to your research.
The convention will take place at RAI Amsterdam (Europaplein, 1078 GZ Amsterdam, The Netherlands):